*together with Mode Mobile
GM 360, here are some of our top movers today!
And check this out → JW’s #1 Pick of the Week drops Mondays in Weekly Wiretaps [new]! Only $97 for a full year… grandfathered in. Lock in this fantastic deal today!
FOCUS LIST🔎
QNTM – Up over 100% in the pre-market after announcing the success of unbuzzd™ clinical trial
IVVD – Up over 16% in pre after announcing positive Phase 1/2 clinical data for alternative to COVID-19 vaccination
PLTR – Up over 19% in pre after increased revenue guidance
*together with Mode Mobile
Today’s Fastest Growing Company Might Surprise You
🚨 No, it’s not the publicly traded tech giant you might expect… Meet $MODE, the disruptor turning phones into potential income generators. Investors are buzzing about the company’s pre-IPO offering.1
📲 Mode saw 32,481% revenue growth from 2019 to 2022, ranking them the #1 overall software company on Deloitte’s most recent fastest-growing companies list2 by aiming to pioneer “Privatized Universal Basic Income“ powered by technology — not government. Their flagship product, EarnPhone, has already helped consumers earn & save $325M+.
🫴 Mode’s Pre-IPO offering1 is live at $0.26/share, and 20,000+ shareholders already participated in its previous sold-out offering. They’ve just been granted the stock ticker $MODE by the Nasdaq1, and you can still invest in their pre-IPO offering at just $0.26/share before it closes.
1 Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.
2 The rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.
3 A minimum investment of $1,950 is required to receive bonus shares. 100% bonus shares are offered on investments of $9,950+.
HOTLIST🔥
QNTM – Up over 100% in the pre-market after announcing the success of unbuzzd™ clinical trial
Quantum BioPharma Ltd. (QNTM) is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.
In the pre-market this morning, the company announced that it has completed a double-blind, randomized, placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd™, investigating its effects on alcohol intoxication and alcohol metabolism.
The trial confirmed unbuzzd™ dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, and reduces symptoms of intoxication, impairment and hangover.
The rate at which BAC was lowered was, on average for most participants, more than 40 percent faster within 30 minutes of consuming unbuzzd™ compared to control subjects. This faster reduction of BAC after consuming unbuzzd™ was both statistically significant compared to placebo and was observed at each subsequent measurement of BAC over a four-hour period.
Shares of QNTM traded up over 100% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $7.38. Beyond that, $8.86, $10 and $14.04 come into play, with all-time highs at $23.81 above that.
Below $7.38, targets to the downside are $6.13, $6, $5.70, $5, $4.40 and $4.
IVVD – 2nd day play, up over 16% in pre after yesterday announcing positive Phase 1/2 clinical data for alternative to COVID-19 vaccination, HC Wainwright & Co. reiterates Buy, maintains $10 price target
Invivyd Inc. (IVVD) is a commercial-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
In the pre-market yesterday, the company announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody (mAb) candidate designed to be a superior alternative to COVID-19 vaccination for the broad population as frontline protection in a convenient form, as well as to provide a novel, potent, long-acting option for the treatment of COVID-19.
Shares closed yesterday up over 190% in reaction to the news.
This morning, HC Wainwright & Co. reiterated its Buy rating and maintained a $10 price target.
Shares of IVVD traded up another 26% in the pre-market above yesterday’s close.
The first target for bulls is prior resistance at $1.40 and then the pre-market high at $1.45. Beyond that, $1.63, $1.90, $2 and $2.20 come into play.
Below $1.40, targets to the downside are $1.20, $1.10, $1, $0.90 and $0.80.
PLTR – Up over 19% in pre after increased revenue guidance
Palantir Technologies Inc. (PLTR) builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
In the after-hours yesterday, the company reported $828 million in sales vs $781.2 million expected, a 36% year on year increase. Adjusted profits per share came in at $0.14, above the $0.11 projection.
Looking forward, Palantir forecasts a 31% increase in full-year 2025 revenue, ranging from $3.741 billion to $3.757 billion.
Revenue in the first quarter is projected to fall between $858 million and $862 million. Growing at least 54% year over year, the business projects U.S. commercial income to reach $1.079 billion.
Shares of PLTR traded up over 19% in the pre-market in reaction to the news.
The first target for bulls is the pre-market and all time high at $104.34. Above it is blue sky and round numbers such as $110, $115 and $120 come into play.
Below $104.34, targets to the downside are $100, $98.50, $97.29, $96 and then $90.
MARKET NEWS 📰
Don’t miss out on our MOBILE ALERTS! Some of these alerts have rocketed 🚀past the MOON 🌝. Text “RAGE” to 1-(888) 487-1534 📲.
*Disclosure: By texting “RAGE” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
